ANNY EUSEBIO: Open Payments
NPI 1841323391 · BAYONNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,516 in 50 payments from 13 companies in 2025. Trend: 2023 $1,269 · 2024 $1,721 · 2025 $1,516
Food & beverage: $1,148Travel & lodging: $368
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 5 | $557 |
| BridgeBio Pharma, Inc. | 2 | $226 |
| Novartis Pharmaceuticals Corporation | 18 | $179 |
| Merck Sharp & Dohme LLC | 11 | $161 |
| Novo Nordisk Inc | 1 | $125 |
| Amgen Inc. | 3 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| MEDICOMP INC | 1 | $34 |
| Abbott Laboratories | 2 | $33 |
Products named: Barostim Neo System, Attruby, VERQUVO, LEQVIO, Wegovy, REPATHA, Kerendia, SHINGRIX.
Industry payments across NJ — which companies pay providers there.
